What is Boston Scientific's U.S. — long-lived assets?

Boston Scientific (BSX) reported U.S. — long-lived assets of $1.95B in Q1 2026.

How has Boston Scientific's U.S. — long-lived assets changed year-over-year?

Boston Scientific's U.S. — long-lived assets increased by 28.0% year-over-year, from $1.52B to $1.95B.

Boston Scientific BSX U.S. — Long-Lived Assets

Other geography segments

Ireland

$750M—

Costa Rica

$637M—

Other financials

Income statement

See full

Revenue$5.4B+7.5%

Gross profit$3.8B+12.4%

Operating income$1.2B+43.8%

Net income$907.0M+14.1%

EPS (diluted)$0.61+15.1%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$68.43B-56.7%

P/E18.6×-44.6×

P/S3.3×-5.3×

Profitability

See full

Gross margin69.9%+1.7pp

Operating margin19.8%+2.8pp

Net margin17.5%+4.0pp

FCF margin16.9%-0.3pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's u.s. — long-lived assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's U.S. — long-lived assets?: Boston Scientific (BSX) reported U.S. — long-lived assets of $1.95B in Q1 2026.
How has Boston Scientific's U.S. — long-lived assets changed year-over-year?: Boston Scientific's U.S. — long-lived assets increased by 28.0% year-over-year, from $1.52B to $1.95B.